N. M. Durante

In vitro and in vivo chemosensitizing effect of cyclosporin A on an intrinsic multidrug-resistant rat colon tumour

A. Eggermont, R. Marquet, A. Oosterom, 1993, Journal of Cancer Research and Clinical Oncology.

Synergistic antitumour effect of recombinant human tumour necrosis factor a with melphalan in isolated limb perfusion in the rat

A. Eggermont, A. Eggermont, R. Marquet, 1996, The British journal of surgery.

Modulation of multidrug resistance with dexniguldipine hydrochloride (B8509-035) in the CC531 rat colon carcinoma model

J. Schellens, A. Eggermont, W. Loos, 1996, Journal of Cancer Research and Clinical Oncology.

The value of in vivo electrophysiological measurements for monitoring functional adaptation after massive small bowel resection in the rat.

R. Marquet, E. Heineman, J. Bijman, 1993, Gut.

Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance

R. Pieters, K. Sikora, W. Siegert, 1991, Journal of Cancer Research and Clinical Oncology.

Isolated limb perfusion with TNF alpha and melphalan in a rat osteosarcoma model: a new anti-tumour approach.

A. Eggermont, R. Marquet, E. Manusama, 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Pharmacokinetics of the multidrug-resistance-converting drug dexniguldipine and its pyridine metabolite M-1 in the plasma, tumor, and renal tissue of tumor-bearing Wag / Rij rats

J. Verweij, A. Eggermont, J. Schellens, 1997, Cancer Chemotherapy and Pharmacology.

Ischemia promotes the antitumor effect of tumor necrosis factor alpha (TNFα) in isolated limb perfusion in the rat

A. Eggermont, R. Marquet, E. Manusama, 1994 .

Synergistic antitumour effect of recombinant human tumour necrosis factor a with melphalan in isolated limb perfusion in the rat

A. Eggermont, R. Marquet, P. Nooijen, 1996, The British journal of surgery.